key: cord-0027934-y1t0s082 authors: Garofalo, Robert; Adetunji, Adedotun; Kuhns, Lisa M.; Omigbodun, Olayinka; Johnson, Amy K.; Kuti, Kehinde; Awolude, Olutosin A.; Berzins, Baiba; Janulis, Patrick; Okonkwor, Ogochukwu; Oladeji, Bibilola; Muldoon, Abigail L.; Amoo, Oluwaseun P.; Atunde, Hannah; Kapogiannis, Bill; Taiwo, Babafemi O. title: Evaluation of the iCARE Nigeria Pilot Intervention Using Social Media and Peer Navigation to Promote HIV Testing and Linkage to Care Among High-Risk Young Men: A Nonrandomized Controlled Trial date: 2022-02-22 journal: JAMA Netw Open DOI: 10.1001/jamanetworkopen.2022.0148 sha: 23b90bd945e20fd37cf8b67892e8b9af4ad3798c doc_id: 27934 cord_uid: y1t0s082 IMPORTANCE: Nigeria has the fourth-largest HIV epidemic globally, yet high levels of social stigma inhibit HIV testing among Nigerian youths and young men who have sex with men (MSM). OBJECTIVE: To report pilot data from iCARE Nigeria (Intensive Combination Approach to Roll Back the Epidemic in Nigerian Adolescents), a combination intervention using social media and peer navigation to promote HIV testing and linkage to care among high-risk youths and young men (hereinafter referred to as young men), including predominantly young MSM. DESIGN, SETTING, AND PARTICIPANTS: This nonrandomized controlled study assessed an organizational and community-level 12-month, preintervention-postintervention pilot trial of a combination intervention designed to increase HIV testing uptake, increase the rate of identified seropositive cases, and improve linkage to care among young men, including MSM, using social media outreach and peer navigation. Data were collected from June 1, 2019, to May 30, 2020. Participants were young men aged 15 to 24 years in the city of Ibadan, Nigeria, and surrounding areas. Frequencies and percentages were examined, and a Fisher exact test was used to evaluate outcomes compared with historical surveillance data. Linkage to care was defined as 2 clinic visits, including HIV confirmation, within 2 months of a positive rapid test result. INTERVENTION: Four peer navigators conducted social media outreach promoting sexual health and guiding individuals to HIV counseling and rapid testing in clinical, community, or home-based settings. MAIN OUTCOMES AND MEASURES: Primary outcomes included the number of young men tested for HIV at university-based iCARE catchment clinics or by iCARE peer navigators in the community, the postintervention HIV seroprevalence of these groups, and linkage to care of participants diagnosed with HIV infection. RESULTS: A total of 339 participants underwent testing for HIV (mean [SD] age, 21.7 [1.9] years), with 283 (83.5%) referred through social media. The main referral sources for social media were WhatsApp (124 [43.8%]), Facebook (101 [35.7%]), and Grindr (57 [20.1%]). Regarding testing location, participants chose home (134 [39.5%]), community-based (202 [59.6%]), or clinic (3 [0.9%]) settings. Eighty-six participants reported no prior HIV testing. Thirty-six participants (10.6%) were confirmed as HIV seropositive; among those, 18 (50.0%) reported negative test results within the past year, and 31 (86.1%) were linked to care. In two 6-month follow-up periods, the intervention increased HIV testing by 42% and 31%, respectively, and seroprevalence increased compared with historical trends with odds ratios of 3.37 (95% CI, 1.43-8.02; P = .002) and 2.74 (95% CI, 1.10-7.11; P = .02), respectively. CONCLUSIONS AND RELEVANCE: These findings suggest that use of iCARE Nigeria was associated with increased HIV testing and linkage to care in a high-risk, difficult-to-reach population, making it a promising combination intervention for young MSM. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN94590823 The primary endpoint for pilot study 2 is viral suppression, defined as viral load <200 copies/mL at Week 48 of the intervention. The population for pilot study 1 is the total number of HIV tests completed, and resulting incidence, among youth in/around Ibadan. The study population for pilot study 2 comprise youth living with HIV and receiving antiretroviral therapy (ART) at IDI. This is the UG3 (first; pilot) phase of the iCARE, Nigeria study HIV Program at IDI is supported by the APIN Public Health Initiatives to provide ART to persons living with HIV (PLWH). The combination intervention in each of the pilot studies includes peer navigation and mHealth components The study duration in pilot study 1 is 48 weeks after initiating the intervention, while in pilot study 2 the total study duration is 48 weeks after the last of 40 participants is enrolled, with each participant followed for 48 weeks. influence, and variable self-regulatory capacity for challenging or emotionally sensitive tasks. Evidence also suggests that "simply forgetting" is the most cited barrier to medication adherence, 3 233 indicating this must be addressed in intervention efforts. Cao and colleagues found that Facebook and Grindr were the most widely used platforms to 293 promote HIV testing in high and middle-income countries (gay "chat" rooms and other gay-specific 294 apps were also used); 31 however, these methods have not been fully tested in low income 295 countries. Ibadan revealed the potential utility of mobile phones to improve adherence, though in a 302 predominantly adult population. 36 The SMS component is based on Text Messaging Intervention to 303 Improve Antiretroviral Adherence among HIV-Positive Youth (TXTXT) 37 which uses a two-way 304 daily text reminder and response system designed by Garofalo and colleagues to improve ART 305 adherence among 16-29 year-old U.S. adolescents and young adults. In comparison to the control 306 condition, participants who received the TXTXT intervention were more than twice as likely to 307 report >90% adherence to ART over the 6-month intervention period (OR = 2.12, 95 % CI 1.01- While the original TXTXT intervention focused exclusively on ART adherence, for the purposes of 312 the proposed study, we will adapt the intervention to deliver SMS text reminders not only for ART 313 adherence, but also to focus on critical aspects of retention (e.g. clinic appointment and pharmacy 314 refill reminders) as our primary outcome; viral suppression, is influenced by both. This intervention 315 has not been adapted for use or tested in LMICs. The primary risk to participation in this study is breach of confidentiality (related to being MSM identified 330 or to HIV status). However, the risk to the participant is no greater than that encountered in standard 331 counseling or HIV treatment services. The risk associated with the collection of blood from a vein in the arm (for viral load quantification), include pain or discomfort at the site of collection, temporary bruising 333 at that site and very rarely, the site of blood collection may become infected or need medical treatment. For pilot 1, the HIV testing intervention, we will not enroll participants in research activities in order to 346 reduce the potential risk of breach of confidentiality among YMSM given the criminalization of same-sex 347 sexual behavior in Nigeria. In pilot 2, to protect the integrity of the youth's data, staff will assign each 348 individual a unique patient identification number (PID) at study enrollment. This code number will be 349 used for all study data. Only staff who have been trained in human subjects protection will have access 350 to these PIDs. Possible risks (i.e. potential confidentiality breeches) are outweighed by the new knowledge gained 354 from testing this intervention among the study population, a population at very high risk of poor HIV To determine efficacy of the combination intervention, HIV testing data in the 24 weeks before the weeks post-intervention. HIV testing data for all young men as opposed to YMSM alone is utilized mainly because HIV testing records do not routinely contain valid data on same-sex behavior. As secondary objectives, we will assess, i) the proportion of newly diagnosed youth who are linked to Exploratory analyses will compare the HIV testing data obtained through the study to the data from 404 other local HIV testing locations. In Pilot study 2 (HIV Treatment Outcomes), the combination of Short Message Service (SMS; via 406 adaptation of the TXTXT intervention) + Peer Navigation will be investigated to evaluate their effect on HIV treatment outcomes (viral suppression, ART adherence, and retention in care). We hypothesize that suppression (defined as < 200 copies/mL at 48 weeks) will be more likely post-intervention relative 409 to pre-intervention. We will enroll 40 youth (including virologically suppressed and viremic individuals) with HIV regardless of gender, ages 15-24 yrs who have been on ART for at least 3 months at the HIV clinic in IDI. To reflect the clinic population, enrollment will be monitored to ensure that no more than 35% are 413 suppressed at study entry. Trained peer navigators (one for 5 participants) will be selected from the IDI clinic using the following 415 criteria: i) on ART, ii) virologically suppressed with viral load <200 copies/mL based on viral load in the 416 preceding 12 months, if available, iii) 18 to 30 years of age, and iv) "doing well" according to their 417 physician's subjective assessment. Each peer navigator will navigate 5 youths, by providing practical 418 assistance and other support to optimize adherence. Provided support will be determined through a 419 structured Needs Assessment process that will be conducted at the time of enrollment. In addition, peer 420 navigators will foster a sense of community among the participants in their respective groups. daily, free, bi-directional and personalized text messages, delivered using a secure platform provided 423 by Dimagi CommCare. The SMS will be personalized to remind and encourage the youth to adhere to 424 their ART. Each participant will be followed for 48 weeks. The primary efficacy measure for this combination intervention is the proportion of participants with viral 426 load <200 copies/mL at week 48 of the combination intervention. The secondary measures of efficacy are i) change in adherence (based on pharmacy pick up records, 428 self-report, and hair antiretroviral drug levels) from baseline to weeks 24 and 48, ii) retention in care 429 based on medical records, and iii) feasibility, acceptability and satisfaction. Feasibility, acceptability, and satisfaction will be evaluated through a combination of logs maintained by peer navigators, self and interviewer-administered questionnaires. Exploratory assessments of factors associated with study outcomes will be performed using a socio-demographic and other surveys that 433 will be conducted. The population for pilot study 1 is the total number of HIV tests completed, and resulting incidence, 473 among youth in/around Ibadan. The study population for pilot study 2 comprise youth living with HIV 474 and receiving antiretroviral therapy (ART) at IDI. and during the intervention period (48 weeks) will be abstract from surveillance records for analysis. NB: For the HIV testing and linkage intervention, no human subjects will be enrolled and no identifying 481 data will be collected. Routine HIV testing data from surveillance records at IDI/UCH will be abstracted 482 in a de-identified format. Intervention satisfaction data will be collected in anonymous format. Inclusion criteria: ART. We will monitor enrollment to ensure that no more than 35% of participants at baseline 493 are virally suppressed (<200 copies/ml). Participants who do not meet the eligibility criteria will not be enrolled into the study. The HIV testing and linkage pilot study will reach at-risk youth through social media and in-person 513 outreach conducted by peer navigators, who will be trained to implement the manualized combination 514 intervention, focused on promoting HIV testing and linkage to care. To maximize random enrollment in the HIV treatment outcomes pilot study, a sampling frame will be 516 created for eligible patients from medical records at IDI/UCH and stratified by status as virally 517 suppressed versus viremic. A random sample will then be selected as every "n th " participant based on 518 the final ratio of target sample size to eligible patients in the sampling frame. As needed based on 519 refusals or no-shows, the sampling frame will be re-constituted as a ratio of remaining sample needed 520 to remaining eligible patients. These procedures will be followed until the accrual target of 40 is 521 reached, while ensuring that no more than 35% have viral load < 200 copies/mL. In the event of a large 522 number of refusals or no-shows that prohibits random sampling, the contingency plan will include 523 convenience sampling of clinic patients approached at clinic visits. A screening log will be maintained to track ineligible cases and reasons for ineligibility, as well as 526 refusals and no-shows. that are used and trusted by Nigeria's YMSM. Peer navigator's activities will include using existing or 536 creating new closed groups on these platforms, plus respondent-driven new invitations in order to 537 generate a following. The peer navigators will receive a monthly stipend plus reimbursement for study-538 related expenses as incentive for their efforts. Prior to deployment, the peer navigators will be trained on 1) profile set-up; 2) scripts for messaging, and instructions for structuring the interaction (e.g., how many times to message before moving on, 541 providing responses as quickly as possible); 3) FAQs to guide unscripted interaction (e.g., Don't use 542 your personal profile, Don't exchange personal information/photos; Do stick to pre-approved themes). The social media interactions will promote HIV testing. Peer navigation: Peer navigators will also be trained to conduct community-based outreach and HIV 545 testing, with emphasis placed on flexibility, building trust and maintaining confidentiality. 14,15,20,21 In 546 addition, they will be trained in pre and post-test counseling and in the management of reactions to the 547 test results. HIV testing will be promoted via social media and in-person interactions, e.g., at locations 548 where young people may socialize locally. Social media messaging by peer navigators will focus on the 549 benefits of HIV testing, management of stigmatization of HIV testing, and peer-based social support. The navigator will emphasize the advantages of HIV tests, e.g., "know your status," autonomy for self-551 management, benefits of early diagnosis and treatment. 13 In addition, the navigator will emphasize free 552 testing and confidentiality of treatment. For individuals who express interest in HIV testing, the peer will navigate them based on the youth's 554 preference to either i) IDI/UCH testing site, ii) another testing site that the youth prefers, or iii) HIV test 555 performed by the peer navigator at a location the youth finds comfortable. Youth with a positive HIV test initiation according to national guidelines. Youth who are navigated to HIV testing will be asked to complete an optional, brief, anonymous and self-reported questionnaire regarding their satisfaction with Each peer navigator will meet in person or by phone at least every two weeks with a designated 579 clinic staff to discuss emerging issues with their assigned peers and formulate practical solutions 580 including allocation of funds to participants based on the findings of the Needs Assessment. Funds that are available to the clinic, and are not study-provided (e.g., through philanthropy or indigent fund), may be used to address some of the needs of study participants, based on availability. Peer navigators will receive a small stipend, which includes funds for their 584 transportation/communication costs. SMS text message reminders: This pilot study will utilize a locally adapted version of our CDC-586 recommended, TXTXT intervention. 37 Messaging will consist of daily, free, bi-directional and 587 personalized text messages that will be delivered, using a platform provided by Dimagi CommConnect. 40 All text-related data will be securely stored by Dimagi per their privacy policy. The SMS messages will promote adherence and the content will be selected by and for the participant 590 themselves with consideration given to each person's need for privacy and confidentiality and timed to 591 coincide with individual dosing schedule. Trained peer navigators will use a structured text message tailoring form to elicit message 593 content and then set up automated messages in the Dimagi platform, i.e., set-up daily reminders confidentiality, we will encourage participants to delete text messages after taking medication, to use confidential messages that do not reveal HIV status or mention medications, and we will provide each Participants will have the option to choose a personalized message that may be changed as requested 599 throughout the study period. Bi-directionality is reflected in a series of follow-up messages. Participants will be asked to send 601 a text message response indicating they have successfully taken their ART per schedule. An 602 automated response system provides options for responding, including: 1) "Yes" or 2) "No." If the 603 participant responds, "Yes" an affirmative and encouraging message will be sent in reply (e.g., "Well 604 done!"); a "No" response will trigger an acknowledging and encouraging message (e.g., "You can do 605 it!"). This 2-way message system provides a positive feedback to promote motivation, self-efficacy, and 606 support. Participants will use their own cell phones for receipt of messages, however, we will provide 608 phones to those who do not have them (estimated to be <20% of clinic population) to ensure broad 609 participation. Peer navigator will maintain logs of contacts with participants and phone-related problems The study will terminate upon completion of the study procedures unless premature termination is 633 mandated by the IRB or other constituted authority. Secondary endpoints include linkage to care of newly HIV diagnosed youth who undergo testing 663 through IDI (i.e. tested on site at the IDI/UCH or by a peer navigator during community outreach). This is defined as registration in a clinic where ART is provided, and attendance at one follow up visit in that 665 clinic within two months of registering. These data will be captured in HIV testing encounter forms used 666 for surveillance purposes and tracked using an anonymous identification number. We will also evaluate, as secondary objective, the feasibility and acceptability of the intervention via: a) The anonymous satisfaction questionnaire will be deployed via the secure data capture system, REDCap, hosted at Northwestern University. A remote link to the survey will be sent to those who 680 complete HIV testing by a peer navigator. Aggregate social media tracking data and HIV testing 681 encounter data will be entered into REDCap and stored for analysis. Pilot study 2 (HIV Treatment Outcomes) Study data will be collected at baseline (enrollment), Weeks 24 and 48 (See Schedule of Events, 685 Section 1.3) The primary endpoint for the HIV treatment intervention study is viral suppression defined as HIV < 200 687 copies/mL at week 48. We will collect blood via venipuncture for HIV viral load quantification at Entry 688 and Week 48. Approximately 10 mL will be collected for this purpose and analyzed at the HIV Reference Laboratory, Virology Department, University of Ibadan, Nigeria. Secondary endpoints are: abstracted from lab reports or medical records and entered into REDCap for storage and analysis. Feasibility data will be collected and stored using administrative records and tracking logs. Self- reported adherence, acceptability and satisfaction, and additional psychosocial assessments will be collected using computer-assisted interviewer administered format. Participant safety will be monitored through weekly review of peer navigation activity logs and encounter forms and monthly tallies of completed satisfaction questionnaires. In addition, both study staff and peer navigators will be encouraged to report concerns about safety directly to the UI Principal Investigator (Prof. Olayinka Omigbodun). If any study staff discovers any untreated condition (e.g., onset of physical or mental health condition), they will refer the participant to appropriate treatment 741 immediately. The other members of the core investigative team (Profs. Robert Garofalo and Babafemi Taiwo) will be informed of any significant safety concerns within 24 hours of the UI PI becoming aware 743 of the event. Participant safety will be discussed at weekly and monthly research meetings, and a 744 written log of all safety events will be maintained. Since breach of confidentiality is a potential safety concern in these pilot studies, all study personnel 747 and peer navigators will be trained regarding privacy and confidentiality. The training will include 748 reviewing possible scenarios and key questions to assess risk. We will train staff to err on the side of AEs and SAEs will be classified by the site investigator as related or not related to the study. AEs, including SAEs, will be collated and presented as part of the study reports Pregnancies that occur in the course of the study will be described in study reports. Since ART is not 797 provided by the pilot studies, pregnancy outcomes will not be tracked by the study team. Acceptability and Satisfaction Hypothesis: The combination intervention will be acceptable to youths 845 and they will be satisfied with the process To assess acceptability of this intervention, we will monitor any complaints or problems that result from 847 social media interactions; and d) results of the brief anonymous satisfaction questionnaire. Exploratory Endpoint: Seroincidence Hypothesis: Post-intervention seroincidence will be higher in the intervention site 852 compared to other local HIV testing locations in Ibadan. Pilot study 2 HIV treatment outcomes 855 Primary Endpoint: Viral Suppression Hypothesis: Viral suppression (defined as < 200 copies/mL at 48 weeks) will be more 858 likely post intervention relative to pre-intervention. Secondary Endpoints: Retention in Care Hypothesis: Retention in care will be greater post-intervention relative to pre-863 intervention. Retention in care is defined as at least two care (non-study) visits to the IDI clinic in the 864 preceding 6 months. Eligible visits include the monthly "Youth Club" that takes place in the IDI clinic or 865 any other non-study-mandated visit 38 Adherence Hypothesis: Adherence will be greater post-intervention relative to pre-intervention. Adherence will be compared both for ART concentration, via hair sample, pharmacy pick-up records 869 (100 minus percentage of days alive but without medication), and self-report (30-day visual analogue 870 scale adherence, 4-day missed doses) Feasibility Hypothesis: The combination intervention will be feasible To evaluate the feasibility of the combination intervention for improving HIV outcomes, we will track the 874 ratio of assigned participants to peer navigator (in comparison to plan) and the number of participants 875 who request phones, and all phone-related problems (e.g., lost phone access, cannot receive text 876 reminders). Intervention fidelity will be determined by the proportion of intervention tasks completed, 877 using a fidelity checklist. Acceptability and Satisfaction Hypothesis: The combination intervention will be acceptable to youths 880 and they will be satisfied with the process To measure acceptability, we will ask participants to self-report the frequency of receipt of text 882 messages and peer navigation services as expected and the degree to which they find these services 883 and messages intrusive/bothersome, and whether the services meet their expectations for privacy. To measure satisfaction, we will use an adapted version of the Client Satisfaction Questionnaire (CSQ-886 8) 54 including rating of the quality and quantity of service, outcome, and general satisfaction. The population for pilot study 1 is the total number of HIV tests completed, and resulting incidence, 902 among youth in/around Ibadan. For pilot study 2, the population will include youth on ART at the IDI For descriptive statistics percentages will be presented for dichotomous outcomes (e.g., seroincidence) 911 and means will be presented for continuous outcomes (e.g., adherence). Similarly, changes between 912 pre and post-intervention periods will be summarized via odds ratios or mean differences. For each of 913 the primary outcome measures, we will compare the pre-intervention period (i.e. 24 weeks before To examine changes in testing of male youth at IDI/UCH we will examine the number of male youths 922 tested during pre-versus post-intervention. Again, we do not expect to have sufficient statistical power 923 for statistical significance but expect an increase of ≥30% in total tests by male youth to be satisfactory. Similarly, we will estimate change in seroincidence by examining odds ratio of the contingency table of ≥2.0 pre-versus post-intervention will indicate be satisfactory evidence of the intervention on 927 seroincidence. Pilot study 2 To estimate the effect of the intervention on viral suppression, we will examine the odds ratio of the 931 contingency table to compare the proportion of participants with viral load <200 copies/mL at study 932 entry baseline) to the proportion at 48 weeks after the introduction of the intervention (in 24-week intervention on viral suppression. Feasibility and Acceptability: Frequency data will be used to provide descriptive estimates on all 944 feasibility and acceptability outcomes. Pilot study 2: Retention in Care: To estimate the effect of intervention on retention in care we will examine the odds 948 ratio of the contingency table of the proportion retained in care pre versus post-intervention. Adherence: To estimate the effect of the intervention on adherence we will examine the mean 951 difference in adherence pre versus post-intervention. Feasibility, Acceptability and Satisfaction: Frequency data will be used to provide descriptive estimates 954 on all feasibility and acceptability outcomes. Safety issues that occur in the course of the studies will be described. In pilot study 1, while no individuals will be enrolled for the purposes of assessment of primary 990 outcomes, individuals who complete HIV testing will be consented prior to completion of the satisfaction 991 survey (via a consent statement with waiver of documentation of consent). For human subjects 992 research in pilot study 2, no research data will be collected prior to informed consent. Consent is 993 conducted in a private room, by trained research staff. The consenting process will ensure autonomy of 994 the youth by explicitly stating that participation in the research is voluntary, and that the youth is free to 995 participate or withdraw at any time. The consenting procedure, among other elements, will cover: a) 996 sources of potential harm (e.g., inadvertent disclosure even if the possibility is remote, or routine risks 997 such as from blood draw); and b) importance of the knowledge to be gained (e.g. findings may improve 998 understanding of how to improve the health for youths living with HIV) While telephones will be provided to a small number of youths who do not have one and a small sum will be made available to facilitate provision of practical support (based on needs assessment) in pilot study 2, there will no overt or covert coercion, enticement or intimidation of the participants. Determining Capacity. The cognitive capacity of youths will be carefully assessed as part of the 1007 consenting process. The trained Study Coordinator will proceed through each component of the consent, written to Nigerian primary school or below reading level, and will make an assessment of the youth's decisional capacity to consent prior to signing. Potential participants will be asked questions designed to assess their capacity to understand what the study is about, appreciate, reason with, and express a choice about participation in the protocol. Parental consent is not required to participate in Pilot Study 2. In compliance with the 2014 Federal Reproductive Health Services in Nigeria, youths 16 years and older or emancipated minors aged 15 years are exempt from parental consent. This guidance defines an emancipated minor as a person under the age of 18 years who has been granted status of adulthood by a court order, has lived independent of parental guidance of at least a year, is married, living on the street, or is head of a 1020 household. Parental consent may decrease participation rates because some youth will fear that their HIV status research do not pose more than "minimal risk" to participants To compensate for waiver of parental periodic review of safety data and study progress. This evaluation will occur 24 weeks after initiating will occur annually thereafter for the duration of the study. An evaluation can be requested by the study at any time if there are concerns about participants' safety in the opinion of the investigators. The study information, 2) informed consent, 3) any paper data forms. The first two have identifying information, and are linked to the data by the patient identification number (PID). Computer files consist of the tracking data base, and study data files. Tracking files are maintained in used to schedule and track study visits; it is completely password protected. The tracking data base stores contact preferences; all communications strictly follow the participants' contact limitations. Date Description of Change Brief Rationale . report. Abuja, Nigeria2015. 32 118 consent, participants receive a formal individual assessment of capacity to consent (above) to ensure 1026 their understanding of study goals, procedures, and risks from disclosure of sensitive information. 1027 1028 1029 10.1.1.2 CONSENT PROCEDURES AND DOCUMENTATION 1030 1031 Informed consent as described above must be obtained and documented before any human subjects 1032 research We 1043 will maintain a list of participants with links between identifying information and code numbers to avoid 1044 any duplication in cases and to facilitate follow-up in pilot 2. Only staff who have been trained in human 1045 subjects protection will have access to these lists, which will be kept on a secure server with password 1046 protected access. Consents are stored in a locked cabinet away from workstations and are only 1047 accessed in the event of a consent amendment or an audit. Locator files are kept in a locked cabinet in 1048 the research area, separate from data files Omigbodun is the site PI at University of Ibadan and will oversee all study activities Oversight will be obtained through study-specified notification of both the IRB and the Program Officer if 1059 an SAE and unanticipated event occurs. In addition, a Data Safety Monitoring Board will perform All AEs and SAEs regardless of classification 1082 4. Summary of results from questionnaires and surveys that relate to safety of participants 1083 We have developed systematic protocols for data handling and storage over multiple cohort studies. study sites. Data files do not include information that could be used to identify the participant from the 1102 data file alone This is a secure system and will be further protected by login credentials 1106 for limited access, to protect participant confidentiality. To protect privacy and confidentiality, we will 1107 encourage participants to delete text messages after taking medication, to use confidential messages 1108 that do not reveal HIV status or mention medications, and we will provide each participant with a fact 1109 Data files are exported from REDCap and imported into SPSS database for storage and analysis PUBLICATION AND DATA SHARING POLICY 1120 This protocol will adhere to publications, and data and resource sharing policies of the PATC3H 1121 consortium and will be consistent with the relevant NIH policies, laws and regulations. 1122 1123 10.1.12 CONFLICT OF INTEREST POLICY 1124 Study investigators at UI/UCH and Northwestern University will adhere to their institutional policies for Global AIDS response country progress 4. Nigerian Federal Ministry of Heath. National HIV & AIDS and reproductive health survey High prevalence of HIV, chlamydia and gonorrhoea Nigeria: implications for combination prevention Nigerian Federal Ministry of Heath. National HIV & AIDS and reproductive health survey 2010 (NARHS Plus II) Transactional Sex between Men and Its Implications on 13. World Health Organization. HIV and adolescents: Guidance for HIV testing and counselling and 1169 care for adolescents living with HIV You must do the test to know your status": 1171 attitudes to HIV voluntary counseling and testing for adolescents among South African youth 1172 and parents Brenhouse HC, Andersen SL. Developmental trajectories during adolescence in males and 1176 females: a cross-species understanding of underlying brain changes World Health 1189 Organization;2007. 1190 22. Bennett GG, Glasgow RE. The delivery of public health interventions via the Internet: 1191 actualizing their potential An updated systematic review with a focus on HIV/AIDS and tuberculosis long term management using mobile phones The START Study to evaluate the 1198 effectiveness of a combination intervention package to enhance antiretroviral therapy uptake 1199 and retention during TB treatment among TB/HIV patients in Lesotho: rationale and design of a 1200 mixed-methods, cluster-randomized trial Effects of a mobile phone short message service on Development and pilot testing of an intervention to 29. NCC board and management in a strategic retreat Nigerian 30. Africapractice. The social media landscape in Nigeria A Social Media-Based Intervention Designed to Increase HIV Care Linkage, Retention, and Health Outcomes for Racially and Ethnically Diverse 1218 Effects of Internet popular opinion leaders (iPOL) among The HOPE social Lancet HIV Assessing the viorologic and adherence benefits of patient Engaging HIV-positive clients in care: acceptability and mechanisms of action of a peer navigation program in South Africa Atazanavir concentration in hair is the strongest predictor 1245 of outcomes on antiretroviral therapy Low lopinavir plasma or hair concentrations 1249 explain second-line protease inhibitor failures in a resource-limited setting Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients The use of cell phone support for non-adherent HIV-1256 infected youth and young adults: an initial randomized and controlled intervention trial. AIDS 1257 and behavior The HIV Medication Taking Self-efficacy 1263 Scale: psychometric evaluation Stigma scale revised: Reliability and validity 1265 of a brief measure of stigma for HIV + youth Humeniuk R. Validation of the alcohol, smoking and substance involvement screening test 1270 (ASSIST) and pilot brief intervention: A technical report of phase II findings of the WHO ASSIST 1271 project Assessment of client/patient satisfaction: 1273 Development of a general scale Assessment of client/patient satisfaction: 1275 Development of a general scale As a pilot study, this study is not calibrated to have adequate power to find statistical significance. Adherence, and Retention: Systematic Review and Meta-Analysis. J Med Internet Res.